Cytel Webinar: US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation – September 8th
August 19, 2022
The new drug pricing legislation passed by the US government is set to change the game for the pharmaceutical industry. Medicare will negotiate the prices of certain drugs, so making a convincing case for a drug’s value is more important than ever. In a new Cytel webinar on September 8th, Cytel’s Anna Forsythe and Dr. Edmund Pezalla of Enlightenment Bioconsult will discuss the effects of the new legislation on drug pricing and how to use health economics and outcomes research (HEOR) in value assessment.
According to Cytel, key learning points include:
- Summary of reform and potential impact to pharma industry
- Types of drugs that may be impacted by the reform
- Impact of reform for new and existing drugs
- How private payers may be impacted by this reform?
- Scope for pharma negotiation based on value-based pricing and supporting HEOR evidence?
- How pharma companies can prepare”
To register, click here.
(Source: Cytel, August 19th, 2022)